Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells

Immunobiology

Volumn 218, Issue 1, 2013, Pages 90-95

  Hsu, Shu Ching ^a   Wang, Li Tzu ^a,b   Yao, Chao Ling ^c   Lai, Hsiu Yu ^d   Chan, Kuang Yu ^c   Liu, Bing Sin ^a   Chong, Pele ^a,f   Lee, Oscar Kuang Sheng ^d,e   Chen, Hsin Wei ^a,f  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c YUAN ZE UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

IL 17; Memory T cells; Mesenchymal stem cell; Neutrophil; Phagocytosis

Indexed keywords

INTERLEUKIN 17; RNA;

ARTICLE; BONE MARROW; CD4+ CD45RO+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CONTACT; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; MESENCHYMAL STEM CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANTIGENS, CD45; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-17; MESENCHYMAL STROMAL CELLS; NEUTROPHILS; PHAGOCYTOSIS; T-LYMPHOCYTE SUBSETS; UP-REGULATION;

EID: 84870297158     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.02.007     Document Type: Article

References (44)

1. Adams G.B., Martin R.P., Alley I.R., Chabner K.T., Cohen K.S., Calvi L.M., Kronenberg H.M., Scadden D.T. Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 2007, 25:238-243.
2. Aggarwal S., Ghilardi N., Xie M.-H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
3. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
4. Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010, 33:657-670.
5. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., Milner L.A., Kronenberg H.M., Scadden D.T. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
6. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
7. + T cell activation. Immunol. Lett. 2011, 135:10-16.
8. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
9. + mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin. Exp. Immunol. 2010, 159:292-302.
10. + cells. Stem Cells Dev. 2007, 16:719-731.
11. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G.L., Pistoia V., Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
12. Devine S.M., Cobbs C., Jennings M., Bartholomew A., Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003, 101:2999-3001.
13. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., Jorgensen C., Noel D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005, 52:1595-1603.
14. Dragon S., Saffar A.S., Shan L., Gounni A.S. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. Mol. Immunol. 2008, 45:160-168.
15. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 2011, 208:421-428.
16. Forlow S.B., Schurr J.R., Kolls J.K., Bagby G.J., Schwarzenberger P.O., Ley K. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 2001, 98:3309-3314.
17. Gaffen S.L. An overview of IL-17 function and signaling. Cytokine 2008, 43:402-407.
18. Gao J., Dennis J.E., Muzic R.F., Lundberg M., Caplan A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169:12-20.
19. Ghannam S., Pene J., Torcy-Moquet G., Jorgensen C., Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J. Immunol. 2010, 185:302-312.
20. Glennie S., Soeiro I., Dyson P.J., Lam E.W., Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821-2827.
21. Guo Z., Zheng C., Chen Z., Gu D., Du W., Ge J., Han Z., Yang R. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells. Eur. J. Immunol. 2009, 39:2840-2849.
22. Huang W., La Russa V., Alzoubi A., Schwarzenberger P. Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells. Stem Cells 2006, 24:1512-1518.
23. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
24. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., Chen J.R., Chen Y.P., Lee O.K. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004, 40:1275-1284.
25. Ley K., Smith E., Stark M.A. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol. Res. 2006, 34:229-242.
26. + effector memory T cells. J. Immunol. 2008, 180:7948-7957.
27. Liu S.-J., Tsai J.-P., Shen C.-R., Sher Y.-P., Hsieh C.-L., Yeh Y.-C., Chou A.-H., Chang S.-R., Hsiao K.-N., Yu F.-W., Chen H.-W. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-β and interleukin-6. J. Leukoc. Biol. 2007, 82:354-360.
28. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., Scadden D.T., Ma'ayan A., Enikolopov G.N., Frenette P.S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
29. Mouiseddine M., Francois S., Semont A., Sache A., Allenet B., Mathieu N., Frick J., Thierry D., Chapel A. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br. J. Radiol. 2007, 80(1):S49-S55.
30. Rafei M., Campeau P.M., Aguilar-Mahecha A., Buchanan M., Williams P., Birman E., Yuan S., Young Y.K., Boivin M.N., Forner K., Basik M., Galipeau J. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 2009, 182:5994-6002.
31. Ramasamy R., Fazekasova H., Lam E.W., Soeiro I., Lombardi G., Dazzi F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007, 83:71-76.
32. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., Muroi K., Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007, 109:228-234.
33. Schwarzenberger P., La Russa V., Miller A., Ye P., Huang W., Zieske A., Nelson S., Bagby G.J., Stoltz D., Mynatt R.L., Spriggs M., Kolls J.K. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 1998, 161:6383-6389.
34. Silva M.T. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol. 2010, 87:805-813.
35. Sotiropoulou P.A., Perez S.A., Gritzapis A.D., Baxevanis C.N., Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006, 24:74-85.
36. Spaggiari G.M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M.C., Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
37. + T cells. J. Immunol. 2010, 185:7498-7506.
38. Sudres M., Norol F., Trenado A., Gregoire S., Charlotte F., Levacher B., Lataillade J.J., Bourin P., Holy X., Vernant J.P., Klatzmann D., Cohen J.L. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J. Immunol. 2006, 176:7761-7767.
39. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 2006, 36:2566-2573.
40. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8:726-736.
41. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
42. Xu S., Cao X. Interleukin-17 and its expanding biological functions. Cell. Mol. Immunol. 2010, 7:164-174.
43. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755-1761.
44. Zhang X., Ren X., Li G., Jiao C., Zhang L., Zhao S., Wang J., Han Z.C., Li X. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Invest. Ophthalmol. Vis. Sci. 2011, 52:3143-3152.